Strain Information | |
---|---|
Image | |
BRC No. | RBRC03928 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.B6CB-Psmb11<tm1Smta> |
Former Common name | beta5t KO |
H-2 Haplotype | |
ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
Background strain | C57BL/6 |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | Regulation of CD8+ T cell development by thymus-specific proteasomes. Murata S, Sasaki K, Kishimoto T, Niwa S, Hayashi H, Takahama Y, Tanaka K Science, 316, 1349-1353 (2007). 17540904 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Psmb11 MGI:1921152 | proteasome (prosome, macropain) subunit, beta type, 11 | 14 | Psmb11<tm1Smta> MGI:3716870 | targeted mutation 1, Shigeo Murata | |||
Venus | Yellow Fluorescent Protein (Aequorea victoria) | 14 | Venus | ||||
neo | neomycin resistance gene (E. coli) | 14 | |||||
SV40 polyA signal | 14 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | E.coli Neomycin resistance gene, MC1 promoter, Venus (a derivative of GFP) gene, SV40 PolyA signal |
Research application | Immunology and Inflammation Research |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Science, 316, 1349-1353 (2007). In publishing the research results obtained by used of the biological resource, the recipient must describe the depositor as a coauthor of the study in the first publication only. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE containing Venus, an acknowledgment to Dr. Atsushi Miyawaki and a citation of the following literature(s) designated by the DEPOSITOR are requested. Nat. Biotechnol., 20, 87-90 (2002). |
Depositor | Shigeo Murata (Tokyo Metropolitan Institute of Medical Science) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
Ishii Y, Fukui-Miyazaki A, Iwasaki S, Tsuji T, Hotta K, Sasaki H, Nakagawa S, Yoshida T, Murata E, Taniguchi K, Shinohara N, Ishizu A, Kasahara M, Tomaru U. Impaired immunoproteasomal function exacerbates renal ischemia-reperfusion injury. Exp Mol Pathol 140 104939(2024) 39426027 |
Tomaru U, Konno S, Miyajima S, Kimoto R, Onodera M, Kiuchi S, Murata S, Ishizu A, Kasahara M. Restricted Expression of the Thymoproteasome Is Required for Thymic Selection and Peripheral Homeostasis of CD8+ T Cells. Cell Rep 26(3) 639-651.e2(2019) 30650357 |